Uncertainties in estimating heart doses from 2D-tangential breast cancer radiotherapy
暂无分享,去创建一个
Carsten Brink | S. Darby | C. Brink | M. Ewertz | E. Lorenzen | Marianne Ewertz | Carolyn W Taylor | Sarah C Darby | Ebbe L Lorenzen | C. Taylor
[1] J. Cuzick,et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study , 2007, BMC Cancer.
[2] Per Hall,et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977–2001 , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] Carsten Brink,et al. Automatic segmentation of the heart in radiotherapy for breast cancer , 2014, Acta oncologica.
[4] Joseph O Deasy,et al. CERR: a computational environment for radiotherapy research. , 2003, Medical physics.
[5] J. Sonke,et al. Image-guided radiotherapy for left-sided breast cancer patients: geometrical uncertainty of the heart. , 2012, International journal of radiation oncology, biology, physics.
[6] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[7] Aamer Chughtai,et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. , 2011, International journal of radiation oncology, biology, physics.
[8] Andrew Nisbet,et al. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. , 2007, International journal of radiation oncology, biology, physics.
[9] S. Korreman,et al. IMPACT OF AN OFF-LINE CORRECTION PROTOCOL ON SETUP UNCERTAINTY IN MODERN BREAST CANCER RADIATION THERAPY , 2009 .
[10] M. S. Thomsen,et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group , 2013, Acta oncologica.
[11] J. Bradley,et al. The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation. , 2002, International journal of radiation oncology, biology, physics.
[12] P. Hall,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.
[13] L. Boersma,et al. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume. , 2007, International journal of radiation oncology, biology, physics.
[14] R. Peto,et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. , 2005, The Lancet. Oncology.
[15] L. Holmberg,et al. Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke , 2009, British Journal of Cancer.
[16] S. Darby,et al. Estimating cardiac exposure from breast cancer radiotherapy in clinical practice. , 2009, International journal of radiation oncology, biology, physics.
[17] M. Overgaard,et al. Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience , 2008, Acta oncologica.
[18] P. Hall,et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women , 2003, BMJ : British Medical Journal.
[19] M. S. Thomsen,et al. Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study , 2013, Acta oncologica.
[20] V. Ferrari,et al. Association between tangential beam treatment parameters and cardiac abnormalities after definitive radiation treatment for left-sided breast cancer. , 2008, International journal of radiation oncology, biology, physics.
[21] R Peto,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.